IL-17 suppresses the therapeutic activity of cancer vaccines through the inhibition of CD8+ T-cell responses

Antitumor immunity is mediated by Th1 CD4+ and CD8+ T lymphocytes, which induce tumor-specific cytolysis, whereas Th17 CD4+ T cells have been described to promote tumor growth. Here, we explored th...